What does a hemoglobin of 11.4 g/dL, hematocrit 39.3 %, MCH 29 pg, MCHC 29.0 g/dL, and RDW 18.6 % indicate, and what are the appropriate next diagnostic and treatment steps?

Laboratory Findings Indicate Likely Iron Deficiency Anemia with Elevated RDW

These laboratory values—particularly the low MCHC (29.0 g/dL), elevated RDW (18.6%), and borderline-low hemoglobin (11.4 g/dL)—strongly suggest iron deficiency anemia, and you should immediately check serum ferritin and transferrin saturation to confirm iron deficiency before initiating iron replacement therapy.

Interpretation of the Laboratory Values

Your patient presents with:

• Mild anemia (Hgb 11.4 g/dL)
• Normocytic indices (MCH 29 pg is at lower end of normal)
• Low MCHC (29.0 g/dL, below normal range of 32-36 g/dL)
• Markedly elevated RDW (18.6%, significantly above normal <15%)

The combination of low MCHC with elevated RDW is highly characteristic of iron deficiency. The elevated RDW reflects anisocytosis (variation in red cell size), which occurs as iron-deficient cells are produced alongside older normal cells 1, 2. Recent research demonstrates that RDW ≥16.4% combined with hemoglobin ≤10.3 g/dL achieves 93% sensitivity and 75% specificity for iron deficiency anemia 1. Your patient's RDW of 18.6% exceeds this threshold substantially.

The hematocrit of 39.3% appears discordant with the hemoglobin of 11.4 g/dL (typically Hct should be approximately 3× Hgb). This mathematical inconsistency suggests either a laboratory error or interference that should prompt repeat testing 3.

Immediate Diagnostic Steps

Order these tests now:

1. Serum ferritin - Most important initial test. Use ferritin <45 μg/L as your threshold for iron deficiency in the setting of anemia 4. If ferritin is 45-100 μg/L with inflammatory conditions present, proceed to confirmatory testing.

2. Transferrin saturation - Values <15% confirm iron deficiency and help distinguish absolute from functional iron deficiency 5.

3. Complete blood count with reticulocyte count - Assess bone marrow response. Low reticulocyte count with iron deficiency suggests inadequate iron availability for erythropoiesis 5.

4. Repeat Hgb/Hct - Verify the discordant values, as hemoglobin is more reliable than hematocrit for anemia assessment 5.

Clinical Evaluation Required

Search for the source of iron loss:

• Gastrointestinal evaluation: In non-menstruating patients or those without obvious blood loss, iron deficiency mandates evaluation for GI bleeding. Consider bidirectional endoscopy (EGD and colonoscopy) 4.

• Dietary assessment: Review iron intake, particularly in vegetarians or those with restricted diets 4.

• Menstrual history: In premenopausal women, quantify menstrual blood loss 4.

• Malabsorption screening: Consider celiac disease testing, H. pylori infection, and inflammatory bowel disease 4.

Treatment Algorithm

Once iron deficiency is confirmed:

1. Start with oral iron supplementation unless contraindicated:

   • Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first choices due to cost-effectiveness 4
   • Take on empty stomach when possible, or with meals if not tolerated
   • Adding 500 mg vitamin C enhances absorption 4

2. Consider IV iron if:

   • Severe intolerance to oral iron (nausea, abdominal pain, constipation)
   • Malabsorption conditions (celiac disease, inflammatory bowel disease)
   • Severe anemia requiring rapid correction
   • Chronic kidney disease (see below)

3. Monitor response: Recheck hemoglobin and iron studies in 4-6 weeks. RDW should initially increase further with iron therapy before normalizing as new healthy cells are produced 6.

Critical Caveat: Chronic Kidney Disease

If this patient has CKD, the diagnostic approach changes significantly. In CKD patients, anemia is typically normochromic and normocytic, making it indistinguishable from other chronic conditions 5. The elevated RDW in your patient suggests superimposed iron deficiency rather than pure anemia of CKD. Recent evidence shows that baseline RDW independently predicts response to HIF-prolyl hydroxylase inhibitors in CKD patients, with RDW >13.7% associated with better therapeutic response 7.

Common Pitfalls to Avoid

• Don't assume normal MCV/MCH excludes iron deficiency: These indices have only moderate diagnostic accuracy (AUC 0.68-0.73), and normal values do not exclude empty iron stores 8.

• Don't rely on hematocrit alone: Hemoglobin is more reproducible and not affected by storage time or glucose levels 5.

• Don't miss functional iron deficiency: In inflammatory states, ferritin may be falsely elevated. Use transferrin saturation <15% or consider reticulocyte hemoglobin content if available 5, 9.

• Don't forget to evaluate for thalassemia trait: While less likely given the elevated RDW, beta-thalassemia trait can present with similar indices but typically has RDW <15% 6.